Madison, WI. September 1st, 2017.

Cellular Logistics is pleased to announce that US Patent # 9,744,265, covering the Company’s proprietary biomaterial issued on August 29, 2017. The patent may be viewed here:

US Patent 9,744,265: 3-Dimensional cardiac fibroblast derived extracellular matrix 

About the Company: Cellular Logistics is an early stage life science venture based on research at The Wisconsin Institute for Medical Research (WIMR) at the University of Wisconsin-Madison. The Company is commercializing an acellular biomaterial as a stand-alone therapeutic for cardiac and tissue vascularization applications. The material also provides a cell delivery mechanism for regenerative medicine therapeutics.